Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
about
Identification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring.Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies.Targeting cancer-specific glycans by cyclic peptide lectinomimics.Immunological characterization of a rigid α-Tn mimetic on murine iNKT and human NK cells.Identification of mesothelioma-specific sialylated epitope recognized with monoclonal antibody SKM9-2 in a mucin-like membrane protein HEG1Improving Immunotherapy Through Glycodesign
P2860
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
@ast
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
@en
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
@nl
type
label
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
@ast
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
@en
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
@nl
prefLabel
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
@ast
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
@en
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
@nl
P2860
P3181
P356
P1433
P1476
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
@en
P2093
Katherine A Wall
Md Kamal Hossain
P2860
P3181
P356
10.3390/VACCINES4030025
P407
P577
2016-01-01T00:00:00Z